Scientific Program

Conference Series LLC Ltd invites all the participants across the globe to attend 6th International Conference on Advanced Clinical Research and Clinical Trials Zurich, Switzerland .

Day 1 :

Clinical Research 2018 International Conference Keynote Speaker Lora Black photo
Biography:

Lora Black has professional experience practicing as an Oncology Nurse for over fifteen years, twelve of which focused around oncology clinical research. She has held various positions within the clinical research department at Sanford during her tenure, and currently serves as Senior Director. As Senior Director, she has oversight and responsibility for clinical research performed across the Sanford footprint, which covers six states in the rural Midwest and far-reaching collaborations with national and international health care entities. She provides leadership and strategic vision for clinical research team as well as day-to-day guidance of operations. She holds certifications as an Oncology Certified Nurse and Certified Clinical Research Professional. She completed an MPH from Creighton University with a concentration in Health Policy and Ethics. She is also a Faculty Member for the biomedical ethics program at the South Dakota Sanford School of Medicine.

Abstract:

Although 85% of cancer patients in the United States are treated within the community-based setting, opportunities for advanced treatment options via clinical trials are lacking. The National Comprehensive Cancer Network (NCCN) Guidelines state “NCCN believes that the best management for any patient with cancer is a clinical trial. Participation in clinical trials is especially encouraged” (NCCN 2018). To address the need for clinical trials in the rural communities served by Sanford Health, efforts described here were employed over the last five years to develop and maintain a robust portfolio of clinical trials for physicians to utilize as innovative treatment options. Successful approaches to cultivating an oncology clinical research program include (but are not limited to): developing a relationship with clinical operations, administration, physicians, support staff, research staff, and external partners. Formal trial selection through a protocol review and monitoring committee ensures physician engagement in the process of building a trial portfolio, and assists the study team in identifying feasibility concerns at the outset of considering the trial at the site. Furthermore, leveraging efficiencies of an integrated health care system are critical for study-start up, data collection, and subject coordination – all of which contribute to a site’s ongoing ability to remain attractive for future site selection. In addition, utilizing existing infrastructure for patient care management to screen eligible patients for trial significantly increases institutional enrollment percentages. The complexities of a clinical trial program focused in oncology are wide and varied. However, building a program is not impossible as long as the appropriate commitment, strategy, and dedication of resources are applied.

Keynote Forum

Janett Jalil

Invictus Clinical Research Group, LLC, USA

Keynote: Telemedicine: Its applications and the new era of clinical research
Clinical Research 2018 International Conference Keynote Speaker Janett Jalil photo
Biography:

Janett Jalil obtained her Medical Doctor degree at the Medical Sciences Institute Carlos J. Finlay in Camaguey Cuba. She completed her residency program in Internal Medicine at the same university three years later. She is the Owner and Director of School of Clinical Research USA, LLC, a clinical research site founded in 2010 to conduct industry sponsored clinical research trials and to promote community awareness about clinical research. Most recently, she was invited as an International Jury Member for the European division of the Videomed 2016 medical education media competition.

Abstract:

Telemedicine has changed the face of medicine in the latest years. The number of physicians applying this technology to facilitate
patient access to their services from anywhere around the globe, at any time of the day, is steadily increasing. The potential
applications of this technology in clinical trials are an exciting prospect. Although some major pharmaceutical companies and large
research centers have spearheaded the implementation of telemedicine platforms as part of their common practices, its use has not spread to smaller settings. The potential benefits derived from expanding the use of telemedicine in clinical trials cover critical areas such as safety reporting, data quality, data review and monitoring, among others. At the site level, this means an improved patient experience, and minimal-error, real time data reporting to sponsors.